Literature DB >> 16947018

The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.

Fabrício A Pamplona1, Rui D S Prediger, Pablo Pandolfo, Reinaldo N Takahashi.   

Abstract

RATIONALE: Previous studies demonstrated that pharmacological blockade of CB1 cannabinoid receptors decreases the extinction of conditioned fear and spatial memory in rodents. However, the effects of CB1 cannabinoid receptor activation in this response remain unclear.
OBJECTIVES: To evaluate the effects of the cannabinoid agonist WIN 55,212-2 (WIN) and the cannabinoid antagonist SR 147778 (SR) on the extinction of contextual fear memory in rats 24 h or 30 days after fear conditioning.
METHODS: For fear conditioning, rats were placed in the conditioning chamber for 3 min and received a 1-s electric foot shock (1.5 mA). Retrieval testing consisted of a 3-min exposure to the conditioning chamber and extinction training consisted of successive 9-min exposures at 24-h intervals. Rats were also evaluated in the open field and water maze reversal task.
RESULTS: The administration of SR (1.0 mg/kg, i.p.) and WIN (0.25 mg/kg, i.p.) before extinction training disrupted and facilitated, respectively, the extinction of 24 h contextual fear memory. These effects were not related to any disturbance in memory retrieval, unconditioned freezing expression, or locomotor activity. WIN (0.25 mg/kg, i.p.) also facilitated the extinction of 30-day-old contextual fear memory, while the prior administration of SR (0.2 mg/kg, i.p.) antagonized this response. The facilitative effect of WIN on memory extinction does not seem to be specific for contextual fear memory because it was also observed in the water maze reversal task.
CONCLUSIONS: These results suggest cannabinoid receptor agonists as potential drugs to treat anxiety disorders related to the retrieval of aversive memories.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16947018     DOI: 10.1007/s00213-006-0514-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Prefrontocortical dopamine loss in rats delays long-term extinction of contextual conditioned fear, and reduces social interaction without affecting short-term social interaction memory.

Authors:  Emilio Fernandez Espejo
Journal:  Neuropsychopharmacology       Date:  2002-09-20       Impact factor: 7.853

2.  Crouching as an index of fear.

Authors:  R J Blanchard; D C Blanchard
Journal:  J Comp Physiol Psychol       Date:  1969-03

3.  The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze.

Authors:  Reinaldo Naoto Takahashi; Fabrício Alano Pamplona; Marcelo Soares Fernandes
Journal:  Neurosci Lett       Date:  2005-02-16       Impact factor: 3.046

4.  Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear.

Authors:  Jasmeer P Chhatwal; Michael Davis; Kimberly A Maguschak; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

5.  Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Authors:  Kerry J Ressler; Barbara O Rothbaum; Libby Tannenbaum; Page Anderson; Ken Graap; Elana Zimand; Larry Hodges; Michael Davis
Journal:  Arch Gen Psychiatry       Date:  2004-11

6.  Evaluation of CB1 receptor knockout mice in the Morris water maze.

Authors:  S A Varvel; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

7.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

8.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats.

Authors:  A H Lichtman; K R Dimen; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

10.  The endogenous cannabinoid system controls extinction of aversive memories.

Authors:  Giovanni Marsicano; Carsten T Wotjak; Shahnaz C Azad; Tiziana Bisogno; Gerhard Rammes; Maria Grazia Cascio; Heike Hermann; Jianrong Tang; Clementine Hofmann; Walter Zieglgänsberger; Vincenzo Di Marzo; Beat Lutz
Journal:  Nature       Date:  2002-08-01       Impact factor: 49.962

View more
  61 in total

1.  Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.

Authors:  Laurie A Manwell; Paul E Mallet
Journal:  Psychopharmacology (Berl)       Date:  2014-11-15       Impact factor: 4.530

2.  Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?

Authors:  Stephen A Varvel; Laura E Wise; Aron H Lichtman
Journal:  Drug Dev Res       Date:  2009-12-01       Impact factor: 4.360

3.  Extinction learning of rewards in the rat: is there a role for CB1 receptors?

Authors:  Giovanni Hernandez; Joseph F Cheer
Journal:  Psychopharmacology (Berl)       Date:  2011-04-27       Impact factor: 4.530

Review 4.  Neural and cellular mechanisms of fear and extinction memory formation.

Authors:  Caitlin A Orsini; Stephen Maren
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

Review 5.  The endocannabinoid system and extinction learning.

Authors:  Beat Lutz
Journal:  Mol Neurobiol       Date:  2007-08-17       Impact factor: 5.590

Review 6.  Neural mechanisms of extinction learning and retrieval.

Authors:  Gregory J Quirk; Devin Mueller
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

Review 7.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

Review 8.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

Review 9.  Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers.

Authors:  Marie-France Marin; Sylwia Fowler Lonak; Mohammed R Milad
Journal:  Curr Psychiatry Rep       Date:  2015-06       Impact factor: 5.285

Review 10.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.